The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength.
Superantigens (Sags) induce large-scale stimulation of T lymphocytes by a mechanism distinct from conventional antigen presentation, involving direct MHC binding and stimulation of TCR families based on Vbeta gene usage. The specific Vbeta targets of a given Sag have, since the earliest studies in murine models, been considered a hallmark of that toxin. Bacterial Sags are implicated in the aetiology of a wide range of human diseases, although their role has been most clearly defined in toxic shock syndrome. While Sags have been defined by the Vbeta-specific changes in T cell repertoire they induce, human studies of in vitro stimulation or analysis of cells from infected patients have produced inconsistent findings. Here we have evaluated the contribution of HLA allelic polymorphisms and strength of stimulus to this response. We show that there are differences in binding and presentation of the staphylococcal Sag, staphylococcal enterotoxin A (SEA), by different HLA-DR alleles. We also show that the TCR Vbeta response, previously thought to be a fixed property defining a given Sag, varies with stimulus strength such that a broader repertoire of response is seen at higher concentrations or following presentation by high-binding class II types. Responses of human Vbeta8 and Vbeta1 to SEA, Vbeta5 to SEB and of Vbeta12 and Vbeta13 to streptococcal pyrogenic exotoxin A are absolutely dependent on stimulus strength. These findings have important implications for heterogeneity in the response to Sags and the consequent differences in susceptibility to severe toxic shock.
Llewelyn
Martin
M
Department of Infectious Diseases, Faculty of Medicine, Imperial College, London W12 0NN, UK. m.j.llewelyn@bsms.ac.uk
Sriskandan
Shiranee
S
Terrazzini
Nadia
N
Cohen
Jonathan
J
Altmann
Daniel M
DM
D017951:Antigen Presentation / Q000235:genetics / Q000276:immunology*; D000942:Antigens, Bacterial / Q000276:immunology*; D002460:Cell Line; D020022:Genetic Predisposition to Disease; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology*; D006801:Humans; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000276:immunology*; D012772:Shock, Septic / Q000235:genetics / Q000276:immunology; D018089:Superantigens / Q000276:immunology*
D000942:Antigens, Bacterial; D006684:HLA-DR Antigens; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens